Prophylaxis of catheter-related thrombosis in cancer patients.
Prandoni
Paolo
P
Department of Cardiothoracic and Vascular Sciences, Thromboembolism Unit, University of Padua, 35122 Padua, Italy. paoloprandoni@tin.it
D000925:Anticoagulants / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D019934:International Normalized Ratio; D009369:Neoplasms / Q000188:drug therapy; D016032:Randomized Controlled Trials as Topic; D020246:Venous Thrombosis / Q000209:etiology* / Q000517:prevention & control*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D000970:Antineoplastic Agents; D006495:Heparin, Low-Molecular-Weight; D014812:Vitamin K; D014859:Warfarin